Abstract
We assessed the effects of angiotensin-converting enzyme (ACE) inhibition on survival and cardiorenal outcomes in a consecutive cohort of Chinese type 2 diabetic patients with varying degree of albuminuria, ranging from normoalbuminuria to macroalbuminuria. A total of 3773 consecutive Chinese type 2 diabetic patients were followed prospectively for a mean period of 35.8 months. Clinical end points included all-cause mortality, with cardiovascular end point defined as first hospitalization because of ischemic heart disease, congestive heart failure, revascularization procedures, or cerebrovascular accident as well as renal end point defined as dialysis, doubling of baseline plasma creatinine, or plasma creatinine > or =500 micromol/L. The use of ACE inhibitor was 26.3% in normoalbuminuric (NA), 70.1% in microalbuminuric (MI), and 82.6% in macroalbuminuric (MA) groups. Albuminuria was a major predictor for all-cause mortality with 4-fold difference between NA and MA patients. The 7-year cumulative mortality rate was 7.1%, 10.8%, and 21.7% in the NA, MI, and MA groups, respectively. The use of ACE inhibition was associated with significant reduction of mortality (hazard ratio 0.41 and 95% confidence interval, 0.29, 0.58) in the en...Continue Reading
References
Mar 1, 1985·Diabetes Care·M Laakso, K Pyörälä
Apr 1, 1995·Diabetes Care·C E MogensenM M Pedersen
May 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·K PiwernetzM Krans
Jun 13, 1998·Annals of Internal Medicine·M RavidR Rachmani
Jul 31, 1998·Lancet·A F LeverJ W Robertson
Sep 11, 1998·BMJ : British Medical Journal
Jan 29, 2000·Kidney International·J C ChanC S Cockram
May 2, 2000·Archives of Internal Medicine·C T ValmadridB E Klein
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Oct 6, 2001·Diabetologia·H M ColhounJ H Fuller
Oct 26, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D C Felmeden, G Y Lip
Feb 19, 2002·Kidney International·Robert W SchrierPhilip Mehler
Jul 30, 2003·Circulation·Peter M OkinUNKNOWN Losartan Intervention for Endpoint reduction in hypertension Study Investigations
Citations
Sep 1, 2006·Diabetologia·X L YangJ C N Chan
May 19, 2011·International Journal of Behavioral Medicine·Lal B RawalBrian Oldenburg
Jan 15, 2014·Diabetes Research and Clinical Practice·Juliana C N ChanJonathan Shaw
Apr 9, 2009·Nature Reviews. Cardiology·Varun AgrawalPeter A McCullough
Aug 3, 2005·Journal of Human Hypertension·C E Mogensen
Aug 19, 2006·BMJ : British Medical Journal·Jennifer Y F WuJuliana C N Chan
Jun 9, 2005·Cardiology·Holger ReineckeRoland M Schaefer
Dec 7, 2007·Cardiovascular Diabetology·Xilin YangJuliana C Chan
Nov 3, 2009·Cardiovascular Diabetology·Wilson Y LeungJuliana C Chan
Jan 5, 2008·Clinical and Experimental Nephrology·Marie D PhilipneriKrista L Lentine
Jan 21, 2016·Pharmacoepidemiology and Drug Safety·Yuchen QinJia He
Jun 30, 2006·Kidney International·W B ChanJ C N Chan
Jan 6, 2006·Kidney International·W Y SoJ C N Chan
Oct 18, 2008·Diabetes Research and Clinical Practice·Peter C Y TongJuliana C N Chan
Jun 1, 2009·Journal of Diabetes·Ronald Ching Wan MaJuliana Chung Ngor Chan
Jul 28, 2006·Diabetes/metabolism Research and Reviews·Xilin YangJuliana C N Chan
Nov 10, 2007·Diabetes/metabolism Research and Reviews·Wing Yee SoJuliana C N Chan
Sep 23, 2014·International Journal of Clinical Practice·D Ramírez-PradoV F Gil-Guillén
Nov 26, 2013·Journal of the American College of Cardiology·Miklos Z MolnarCsaba P Kovesdy
Jan 1, 2015·Diabetes Research and Clinical Practice·Juliana C N ChanUNKNOWN JADE Collaborative Study Group
Aug 29, 2006·Diabetes Care·Wing Yee SoPeter C Y Tong
Dec 1, 2017·BMC Nephrology·Phisitt VejakamaAmmarin Thakkinstian
Jun 10, 2011·Current Cardiovascular Risk Reports·Juliana C N ChanXilin Yang
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·Yiming Z Lit, Timothy Meyer
Jan 30, 2007·Diabetes Care·Alice P S KongJuliana C N Chan